These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30214059)

  • 1. NMDA-receptor independent actions of ketamine: a new chapter in a story that's not so old.
    Wray NH; Rasenick MM
    Neuropsychopharmacology; 2019 Jan; 44(1):220-221. PubMed ID: 30214059
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor.
    Kapur S; Seeman P
    Biol Psychiatry; 2001 Jun; 49(11):954-7. PubMed ID: 11398792
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketamine inside neurons?
    Lester HA; Lavis LD; Dougherty DA
    Am J Psychiatry; 2015 Nov; 172(11):1064-6. PubMed ID: 26183700
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on "Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D(2) receptor".
    Krystal JH; D'Souza DC
    Biol Psychiatry; 2001 Oct; 50(7):555-6. PubMed ID: 11600110
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder.
    Castroman PJ; Ness TJ
    Anesthesiology; 2002 Jun; 96(6):1410-9. PubMed ID: 12170054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
    Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
    Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture.
    Wang C; Sadovova N; Hotchkiss C; Fu X; Scallet AC; Patterson TA; Hanig J; Paule MG; Slikker W
    Toxicol Sci; 2006 May; 91(1):192-201. PubMed ID: 16500925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation.
    Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):583-585. PubMed ID: 33433678
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketamine and HTLV-1 myelopathy: NMDA blockade and immunomodulation?
    Prommer E
    J Pain Symptom Manage; 2006 May; 31(5):386-8; author reply 388-9. PubMed ID: 16716866
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketamine and propofol in combination induce neuroapoptosis and down-regulate the expression of N-methyl-D-aspartate glutamate receptor NR2B subunit in rat forebrain culture.
    Fu L; Tang R; Bao N; Wang J; Ma H
    Pharmazie; 2011 Oct; 66(10):771-6. PubMed ID: 22026159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons.
    Väisänen J; Lindén AM; Lakso M; Wong G; Heinemann U; Castrén E
    Neuropsychopharmacology; 1999 Jul; 21(1):137-46. PubMed ID: 10379528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex.
    Shen G; Han F; Shi WX
    Neuroscience; 2018 Aug; 384():178-187. PubMed ID: 29859979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.
    Skoblenick K; Everling S
    J Cogn Neurosci; 2014 Mar; 26(3):577-92. PubMed ID: 24188365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
    Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
    Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA-R inhibition affects cellular process formation in Tilapia melanocytes; a model for pigmented adrenergic neurons in process formation and retraction.
    Ogundele OM; Okunnuga AA; Fabiyi TD; Olajide OJ; Akinrinade ID; Adeniyi PA; Ojo AA
    Metab Brain Dis; 2014 Jun; 29(2):541-51. PubMed ID: 24242214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
    Shim SS; Adityanjee
    Arch Gen Psychiatry; 2002 May; 59(5):466-7; author reply 467-8. PubMed ID: 11982452
    [No Abstract]   [Full Text] [Related]  

  • 17. Blocking NMDA receptor at rest: a possible alleviation of depression.
    Lu W
    Acta Pharmacol Sin; 2011 Sep; 32(9):1087-8. PubMed ID: 21804573
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of NMDA receptor antagonism on spine density.
    Ruddy RM; Chen Y; Milenkovic M; Ramsey AJ
    Synapse; 2015 Jan; 69(1):52-6. PubMed ID: 25220437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series.
    Nunes MV; Adelino MPM; Ajub E; Quarantini LC; Lacerda ALT
    Schizophr Res; 2018 Dec; 202():394-396. PubMed ID: 29935883
    [No Abstract]   [Full Text] [Related]  

  • 20. NMDA receptor blockade: from the laboratory to clinical application.
    Ben-David B
    Anesth Analg; 2000 Oct; 91(4):1042-3. PubMed ID: 11004081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.